High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

By Beller U.   Halle D.   Catane R.   Kaufman B.   Hornreich G.   Levy-Lahad E.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations

By Casey Murray   Bewtra Chhanda  

Familial Cancer, Vol. 3, Iss. 3-4, 2004-09 ,pp. : 265-281

Springer Publishing Company

Access to resources Recommend Favorite

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite

Clinical management of women with genomic BRCA1 and BRCA2 mutations*

By Chang J.   M. Elledge R.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 101-113

Springer Publishing Company

Access to resources Recommend Favorite

Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing

By Kram Vardit   Perez Tamar   Sagi Michal  

Familial Cancer, Vol. 6, Iss. 1, 2007-03 ,pp. : 159-159

Springer Publishing Company

Access to resources Recommend Favorite